v3.26.1
Note 16 - Shareholder's Equity (Details Textual)
$ / shares in Units, $ / shares in Units, $ in Millions
 10 Months Ended 12 Months Ended
Dec. 31, 2025
CAD ($)
shares
Oct. 22, 2025
CAD ($)
$ / shares
shares
Apr. 14, 2025
CAD ($)
$ / shares
shares
Apr. 14, 2025
USD ($)
$ / shares
shares
Nov. 27, 2024
CAD ($)
$ / shares
shares
Nov. 27, 2024
USD ($)
$ / shares
shares
Sep. 09, 2024
Mar. 21, 2024
USD ($)
$ / shares
shares
Feb. 27, 2024
CAD ($)
$ / shares
shares
Feb. 12, 2024
Oct. 22, 2025
CAD ($)
$ / shares
shares
Dec. 31, 2025
CAD ($)
$ / shares
shares
Dec. 31, 2024
CAD ($)
shares
Dec. 31, 2023
CAD ($)
Apr. 14, 2025
$ / shares
Feb. 13, 2023
Statement Line Items [Line Items]                                
Payments for share issue costs                       $ (0) $ (0) $ 284,000    
Transaction costs                       0 180,000 1,582,000    
Wages and salaries                 $ 134,000     $ 6,513,000 $ 4,318,000 $ 3,775,000    
Increase (decrease) in number of shares outstanding, performance based incentive payment (in shares) | shares                 41,314              
Shares issued, price per share (in dollars per share) | $ / shares                 $ 3.24              
The 2028 notes [member]                                
Statement Line Items [Line Items]                                
Shares issued, price per share (in dollars per share) | $ / shares               $ 2.5756                
Increase (decrease) in number of shares outstanding, conversion of interest on convertible instruments (in shares) | shares               210,760                
Borrowings               $ 51.0                
Borrowings, interest rate               8.99%               8.99%
The 2027 notes [member]                                
Statement Line Items [Line Items]                                
Proceeds from issuing shares           $ 5.0                    
Borrowings, interest rate         12.00%                      
Pre-funded warrants [member]                                
Statement Line Items [Line Items]                                
Number of other equity instruments exercised or vested in share-based payment arrangement                       5,330,000        
Increase (decrease) through warrant exercises, equity                       $ 7,302,000        
Number of other equity instruments granted in share-based payment arrangement                       31,735,657        
Weighted average fair value at measurement date, other equity instruments granted $ 29,309,000 $ 73,309,000                 $ 73,309,000 $ 29,309,000        
The 2026 warrants [member]                                
Statement Line Items [Line Items]                                
Number of other equity instruments exercised or vested in share-based payment arrangement                       2,481,786        
Increase (decrease) through warrant exercises, equity                       $ 9,066,000        
Proceeds from exercise of warrants                       $ 4,894,000        
Number of other equity instruments granted in share-based payment arrangement     3,125,000 3,125,000               3,125,000        
Class of warrants or rights, shares issuable per warrant (in shares) | shares     1                          
Class of warrant or right, exercise price (in dollars per share) | $ / shares     $ 1.4                          
Weighted average share price, other equity instruments granted (in CAD per share) | $ / shares                       $ 1.11        
Expected volatility, other equity instruments granted     85.00% 85.00%                        
Risk free interest rate, other equity instruments granted 2.55%                              
Initial recognition, fair value of warrants issued     $ 1,150,000                          
Broker warrants [member]                                
Statement Line Items [Line Items]                                
Number of other equity instruments exercised or vested in share-based payment arrangement                       65,544        
Increase (decrease) through warrant exercises, equity                       $ 42,000        
Proceeds from exercise of warrants                       $ 103,000        
Weighted average fair value at measurement date, other equity instruments granted   $ 4,604,000                 $ 4,604,000          
Weighted average exercise price of other equity instruments granted in share-based payment arrangement (in dollars per share) | $ / shares   $ 2,416,884                            
Weighted average share price, other equity instruments granted (in CAD per share) | $ / shares   $ 2.31                            
Expected volatility, other equity instruments granted   124.31%                            
Risk free interest rate, other equity instruments granted   2.39%                            
Initial recognition, fair value of warrants issued   $ 18,597,000                            
Price per share purchasable by warrants (in CAD per share) | $ / shares   $ 0.75                 $ 0.75          
Non-brokered private placement tranche one and two [member]                                
Statement Line Items [Line Items]                                
Proceeds from issuing shares     $ 4,908,000 $ 3.5                        
Number of other equity instruments granted in share-based payment arrangement     3,125,000 3,125,000                        
Warrants issued price per unit (in dollars per share) | $ / shares                             $ 1.12  
Units issued, shares issuable per unit (in shares) | shares     1 1                        
Finders Warrants [member]                                
Statement Line Items [Line Items]                                
Number of other equity instruments granted in share-based payment arrangement     183,333 183,333                        
Finders fees related to equity offering     $ 338,000                          
Weighted average fair value at measurement date, other equity instruments granted     $ 109,000                          
Weighted average exercise price of other equity instruments granted in share-based payment arrangement (in dollars per share) | $ / shares       $ 1.12                        
Weighted average share price, other equity instruments granted (in CAD per share) | $ / shares     $ 1.5                          
Expected volatility, other equity instruments granted     85.00% 85.00%                        
Risk free interest rate, other equity instruments granted     2.58% 2.58%                        
New equity offering [member]                                
Statement Line Items [Line Items]                                
Number of other equity instruments granted in share-based payment arrangement   46,000,000                            
Units issued, shares issuable per unit (in shares) | shares   1                            
Equity offering, commission   $ 1,851                            
New equity offering warrants [member]                                
Statement Line Items [Line Items]                                
Number of other equity instruments granted in share-based payment arrangement                       46,000,000        
Class of warrants or rights, shares issuable per warrant (in shares) | shares   1                 1          
Class of warrant or right, exercise price (in dollars per share) | $ / shares   $ 0.75                 $ 0.75          
Weighted average fair value at measurement date, other equity instruments granted $ 28,410 $ 79,562                 $ 79,562 $ 28,410        
Weighted average share price, other equity instruments granted (in CAD per share) | $ / shares                     $ 2.31 $ 1.11        
Expected volatility, other equity instruments granted                     87.00% 90.00%        
Risk free interest rate, other equity instruments granted                     2.39% 2.81%        
Price per share purchasable by warrants (in CAD per share) | $ / shares   $ 1.25                 $ 1.25          
The 2027 warrants [member]                                
Statement Line Items [Line Items]                                
Number of other equity instruments granted in share-based payment arrangement         1,136,364 1,136,364                    
Class of warrant or right, exercise price (in dollars per share) | $ / shares         $ 4                      
Weighted average fair value at measurement date, other equity instruments granted         $ 1,221,000                      
Payments for share issue costs         694,000                      
Transaction costs         89,000                      
Deferred share units [member]                                
Statement Line Items [Line Items]                                
Number of other equity instruments exercised or vested in share-based payment arrangement                       (0) 18,568      
Number of other equity instruments granted in share-based payment arrangement             33,891         271,000 33,891      
Restricted share units [member]                                
Statement Line Items [Line Items]                                
Number of other equity instruments exercised or vested in share-based payment arrangement                       26,975 130,414      
Number of other equity instruments granted in share-based payment arrangement                   26,235   179,000 26,235      
Performance share units [member]                                
Statement Line Items [Line Items]                                
Number of other equity instruments exercised or vested in share-based payment arrangement                       (0) 2,083      
Ordinary shares [member]                                
Statement Line Items [Line Items]                                
Number of shares outstanding (in shares) | shares 98,982,239                     98,982,239 14,809,197      
Increase (decrease) in number of shares outstanding, exercise of restricted shares and stock options (in shares) | shares                       15,340        
Proceeds from issuing shares         1,401,000                      
Residual balance, common shares issued     $ 3,759,000                          
Payments for share issue costs         $ 180,000                      
Transaction costs   $ 5,078,000 338,000                          
Price per share purchasable by warrants (in CAD per share) | $ / shares   $ 1.25                 $ 1.25          
Shares issued, price per share (in dollars per share) | $ / shares           $ 2.172                    
Increase (decrease) in number of shares outstanding, issue of equity (in shares) | shares         460,405 460,405                    
Ordinary shares [member] | The 2027 notes [member]                                
Statement Line Items [Line Items]                                
Increase (decrease) in number of shares outstanding, issue of equity (in shares) | shares         443,225 443,225                    
Restricted share units [member]                                
Statement Line Items [Line Items]                                
Increase (decrease) in number of shares outstanding, exercise of restricted shares and stock options (in shares) | shares                       26,975        
Restricted shares and ordinary shares [member]                                
Statement Line Items [Line Items]                                
Proceeds from exercise of restricted shares and stock options                       $ 39,000        
Ordinary shares and warrants [member]                                
Statement Line Items [Line Items]                                
Residual balance, common shares issued   $ 29,720,000                            
Payments for share issue costs   $ 8,240,000 $ 447,000